Insider Trading30 Sept 2026, 05:21 pm
Evoq Remedies Closes Trading Window for Insiders
AI Summary
Evoq Remedies Ltd has announced the closure of its trading window for directors, promoters, designated persons, and insiders. This restriction will be in effect from Thursday, October 1, 2026, until 48 hours after the declaration and publication of the unaudited financial results for the half-year ended September 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, aimed at preventing insider trading.
Key Highlights
- Trading window closed for directors, promoters, and insiders.
- Restriction effective from October 1, 2026.
- Closure lasts until 48 hours post-financial results announcement.
- Aims to prevent insider trading activities.
- Complies with SEBI regulations and company code.
Price Impact
More from EVOQ